Clinical Trial: Procalcitonin as a Prognostic Predictor in Patients With Acute Infectious Disease Hospitalized in the Internal Medicine Department.

U.S., Aug. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07770334) titled 'Procalcitonin as a Prognostic Predictor in Patients With Acute Infectious Disease Hospitalized in the Internal Medicine Department.' on Aug. 10.

Brief Summary: Procalcitonin is a well-known biomarker used to distinguish between bacterial and viral infections, assess a patient's risk category, and serve as a prognostic indicator. However, existing data are derived primarily from relatively young patients in intensive care units; there is a lack of information regarding the prognostic significance of procalcitonin in older patients hospitalized in internal medicine wards.

Study Start Date: Sept. 01

Study Type: OBSERVATIONAL

Conditi...